Device Trial Radar · NCT07153900
BACK4 Safety Evaluation
Last checked: Nov 19, 2026Latest source record: Jan 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Oct 1, 2025
Primary completion
Nov 30, 2025
Study completion Dec 25, 2025
Sponsor
- Lead sponsor
- SWIMS America Corp.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 4, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To characterize the safety of combined RF and EMS therapies with the BACK4 device in healthy volunteers. Subjects will receive 3 treatments of increasing intensity over a one week period.
Conditions
- Safety and Tolerability in Healthy Subjects
Interventions
Treatment with BACK4 SystemDevice
Use of combined RF and EMS therapy with BACK4 Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with a reported Adverse EventTime frame: 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
RORE Method
Birmingham, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.